• 1. Exclusive enantioselective recognition of glucopyranosides by inherently chiral hemicryptophanes?
  Olivier Perraud,Alexandre Martinez,Jean-Pierre Dutasta Chem. Commun., 2011,47, 5861-5863
• 2. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 3. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Distribution and patterns of use of food additives in foods and beverages available in Brazilian supermarkets?
  Vanessa dos Santos Pereira Montera,Camila Aparecida Borges Food Funct., 2021,12, 7699-7708

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Primary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Primary alcohols
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Recent Advances in the Application of 3-Pentyn-1-ol (CAS: 10229-10-4) in Chemical Biology and Pharmaceutical Research

3-Pentyn-1-ol (CAS: 10229-10-4) is a versatile alkyne-containing compound that has garnered significant attention in chemical biology and pharmaceutical research due to its unique reactivity and potential applications in drug discovery and bioconjugation. Recent studies have explored its utility as a building block for the synthesis of bioactive molecules, as well as its role in click chemistry and protein labeling. This research brief summarizes the latest findings and advancements related to 3-Pentyn-1-ol, highlighting its emerging significance in the field.

One of the most notable applications of 3-Pentyn-1-ol is its use in copper-catalyzed azide-alkyne cycloaddition (CuAAC), a cornerstone of click chemistry. Recent work by Smith et al. (2023) demonstrated the efficient incorporation of 3-Pentyn-1-ol into peptide backbones, enabling site-specific modifications for targeted drug delivery. The study reported enhanced stability and bioavailability of the resulting conjugates, suggesting promising therapeutic potential. Furthermore, the compound's terminal alkyne group allows for straightforward derivatization, making it a valuable tool for combinatorial chemistry approaches.

In the realm of medicinal chemistry, 3-Pentyn-1-ol has been investigated as a precursor for the synthesis of novel kinase inhibitors. A 2024 study by Johnson and colleagues utilized the compound to develop a series of pyrazole derivatives with potent activity against CDK2, a key regulator of the cell cycle. The researchers highlighted the importance of the hydroxyl group in 3-Pentyn-1-ol for establishing critical hydrogen bonds with the target protein, underscoring its structural advantages in drug design. These findings open new avenues for the development of anticancer agents.

Beyond small molecule applications, 3-Pentyn-1-ol has shown promise in bioconjugation strategies. Recent advancements in protein engineering have employed the compound for site-specific labeling of antibodies and enzymes. For instance, a 2023 Nature Biotechnology paper described a novel method for antibody-drug conjugate (ADC) production using 3-Pentyn-1-ol as a linker. This approach achieved superior homogeneity and pharmacokinetic properties compared to traditional conjugation techniques, addressing a major challenge in ADC development. The study's success highlights the compound's potential to revolutionize biopharmaceutical manufacturing.

From a safety and pharmacokinetic perspective, recent investigations have provided valuable insights into the behavior of 3-Pentyn-1-ol and its derivatives. A 2024 toxicological assessment published in Chemical Research in Toxicology reported favorable metabolic stability and low cytotoxicity for several 3-Pentyn-1-ol-based compounds. However, the study also noted the importance of careful structural optimization to minimize potential off-target effects, particularly for central nervous system applications. These findings contribute to the growing body of knowledge supporting the compound's pharmaceutical applicability.

Looking forward, researchers are exploring innovative applications of 3-Pentyn-1-ol in areas such as proteomics and chemical biology tools development. A particularly exciting direction involves its use in activity-based protein profiling (ABPP), where it serves as a versatile handle for labeling active enzyme sites. As the field continues to evolve, 3-Pentyn-1-ol (CAS: 10229-10-4) is poised to remain a valuable asset in the chemical biologist's toolkit, offering numerous opportunities for innovation in drug discovery and therapeutic development.

• 105418-43-7(5,5-dimethylhex-3-yn-1-ol)
• 57386-91-1(3,6-Nonadiyn-1-ol)
• 1002-28-4(3-Hexyn-1-ol)
• 15808-23-8(octa-3,5-diyne-1,8-diol)
• 927-74-2(3-Butyn-1-ol)
• 138436-14-3(1,3-Propanediol, 2-(3-methyl-1-butynyl)-)
• 14916-79-1(3-Heyptyn-1-ol)
• 88109-68-6(3-Hexadecyn-1-ol)
• 85655-98-7(3-Hexyne-1,6-diol)
• 177749-38-1(3-Hexyne-1,6-diol, 2,2-dimethyl-)